Skip to main content
. 2022 Aug 2;29(9):1028–1036. doi: 10.1097/GME.0000000000002018

TABLE 3.

Cannabis use information: comparison of perimenopausal and postmenopausal survey participants (two-tailed)

Cannabis use variables All respondents, N = 250 Perimenopausal, n = 126 Postmenopausal, n = 124 Perimenopausal vs postmenopausal
n (%) or Mean ± SD n (%) or Mean ± SD n (%) or Mean ± SD χ2 or F (P)
Tried cannabis (lifetime) 0.94 (0.33)
 No 20 (8.0%) 8 (6.3%) 12 (9.7%)
 Yes 230 (92.0%) 118 (93.7%) 112 (90.3%)
Age first tried cannabis a 19.57 ± 9.73 20.73 ± 10.52 18.34 ± 8.70 3.50 (0.06)
History of regular cannabis usea,b 0.03 (0.86)
 No 38 (16.5%) 19 (16.1%) 19 (17.0%)
 Yes 192 (83.5%) 99 (83.9%) 93 (83.0%)
Cannabis use (current)a 1.70 (0.19)
 No 32 (13.9%) 13 (11.0%) 19 (17.0%)
 Yes 198 (86.1%) 105 (89.0%) 93 (83.0%)
Type of current cannabis usec 1.29 (0.53)
 Mixed use (recreational and medical) 102 (51.5%) 51 (48.6%) 51 (54.8%)
 Recreational only 61 (30.8%) 36 (34.3%) 25 (26.9%)
 Medical only 35 (17.7%) 18 (17.1%) 17 (18.3%)
Current modes of usea,d
 Smoke (e.g., joint, bowl, bong) 194 (84.3%) 95 (80.5%) 99 (88.4%) 2.71 (0.10)
 Edible 180 (78.3%) 99 (83.9%) 81 (72.3%) 4.53 (0.03)
 Vape oil 121 (52.6%) 57 (48.3%) 64 (57.1%) 1.80 (0.18)
 Tincture 93 (40.4%) 52 (44.1%) 41 (36.6%) 1.33 (0.25)
 Vape flower 86 (37.4%) 42 (35.6%) 44 (39.3%) 0.34 (0.56)
 Topical 59 (25.7%) 26 (22.0%) 33 (29.5%) 1.66 (0.20)
 Capsule 27 (11.7%) 14 (11.9%) 13 (11.6%) <0.01 (0.95)
 Transdermal 9 (3.9%) 2 (1.7%) 7 (6.3%) 3.17 (0.08)
 Suppository/lubricant 8 (3.5%) 4 (3.4%) 4 (3.6%) 0.01 (0.94)
 Other 0 (0.0%) 0 (0.0%) 0 (0.0%)

Bold numbers are significant at P ≤ 0.05.

SD, standard deviation.

aOnly answered if respondent reported trying cannabis (n = 230; perimenopausal = 118; postmenopausal = 112); one postmenopausal respondent did not provide age of last cannabis use (n = 111).

bRegular cannabis use was defined as the respondent reporting any period of time using cannabis at least once per month.

cOnly answered if respondent reported current cannabis use (n = 198; perimenopausal = 105; postmenopausal = 93).

dRespondents were instructed to select all items that applied.